Study details
Enrolling now
A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers
Organogenesis
NCT IDNCT06618612ClinicalTrials.gov data as of Apr 2026
Target enrollment
170
Study length
about 2.3 years
Ages
18+
Locations
1 site in OH
About this study
Researchers are testing whether a new treatment, PuraPly AM or XT, combined with standard care helps heal non-healing diabetic foot ulcers better than standard care alone. The trial will last for 822 days and involve approximately 170 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Standard of Care
- 2.Use PuraPly AM
- 3.Use PuraPly XT
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: The number of adverse events.